Having had the honor and pleasure to lead an NCI-designated cancer center for several years, I would like to share my thoughts on this small yet unique set of institutes and their value to NCI and the nation.
Sir Paul Nurse is the recipient of the 26th Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. A geneticist and cell biologist who shared the 2001 Nobel Prize in Physiology or Medicine, Nurse is founding director and chief executive officer of the Francis Crick Institute in London.
Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer cells.
Insights into the workings of PD-1 reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.